Work

TCT-206 Tailoring the Intensity of Antiplatelet Pharmacotherapy to Ischemic and Bleeding Risk: A Cost Optimizing Simulation From PARIS

Year: 2016

Type: article

Source: Journal of the American College of Cardiology

DOI: 10.1016/j.jacc.2016.09.257

Authors: Daniel Leisman, Usman Baber, David Cohen, C. Michael Gibson, Stuart Pocock, Timothy Henry, Philippe Gabriel Steg, George Dangas, David Moliterno, Bernhard Witzenbichler, Annapoorna Kini, Mitchell Krucoff, Jeffrey Bruckel, Antonio Colombo, Alaide Chieffo, Roxana Mehran

Institutions: Icahn School of Medicine at Mount Sinai, Saint Luke's Hospital, Beth Israel Deaconess Medical Center, London School of Hygiene & Tropical Medicine, Cedars-Sinai Medical Center, Hôpital Bichat-Claude-Bernard, University of Kentucky, Helios Amper-Klinikum Dachau, Duke Medical Center, Duke Clinical Research Institute, University of Rochester Medicine, IRCCS Ospedale San Raffaele, Cardiovascular Research Foundation

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2544460836

FWCI:

Cites:

Cited by:

Related to: 10